×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IVA – inventiva s.a. - american depository shares (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/28
08:41 am
iva
Inventiva S.A. (NASDAQ: IVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Inventiva S.A. (NASDAQ: IVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
3/26
04:00 pm
iva
Inventiva reports its 2024 full year results and provides a business update
Medium
Report
Inventiva reports its 2024 full year results and provides a business update
3/19
04:00 pm
iva
Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
Low
Report
Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
2/26
04:00 pm
iva
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
Medium
Report
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
2/21
08:16 am
iva
Inventiva S.A. (NASDAQ: IVA) is now covered by analysts at TD Cowen. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Inventiva S.A. (NASDAQ: IVA) is now covered by analysts at TD Cowen. They set a "buy" rating and a $10.00 price target on the stock.
2/20
04:00 pm
iva
Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
Low
Report
Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial
2/10
04:00 pm
iva
Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update
Medium
Report
Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update
1/30
12:45 pm
iva
Inventiva S.A. (NASDAQ: IVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Medium
Report
Inventiva S.A. (NASDAQ: IVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/26
04:57 pm
iva
Form SCHEDULE 13G Inventiva S.A. Filed by: PERCEPTIVE ADVISORS LLC
Medium
Report
Form SCHEDULE 13G Inventiva S.A. Filed by: PERCEPTIVE ADVISORS LLC
3/26
04:24 pm
iva
Form 6-K Inventiva S.A. For: Mar 26
Medium
Report
Form 6-K Inventiva S.A. For: Mar 26
2/20
04:30 pm
iva
Form 6-K Inventiva S.A. For: Feb 20
High
Report
Form 6-K Inventiva S.A. For: Feb 20
2/14
04:23 pm
iva
Form SCHEDULE 13G/A Inventiva S.A. Filed by: Sofinnova Crossover I
Medium
Report
Form SCHEDULE 13G/A Inventiva S.A. Filed by: Sofinnova Crossover I
2/14
04:06 pm
iva
Form SCHEDULE 13G/A Inventiva S.A. Filed by: Broqua Pierre
Medium
Report
Form SCHEDULE 13G/A Inventiva S.A. Filed by: Broqua Pierre
2/10
04:27 pm
iva
Form 6-K Inventiva S.A. For: Feb 10
Medium
Report
Form 6-K Inventiva S.A. For: Feb 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: